Company / Operating Cash Flow
Imunon, Inc. Operating Cash Flow History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$23.1M
FY2023
5-year range
-$23.1M / -$7.0M
FY2019-FY2023
Trend
-42.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 7 years, ranging from -$23M in FY2023 to -$7M in FY2019.
Based on SEC 10-K filings.
-$23M in FY2023.
Declined from -$16M to -$23M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating cash flow decreased 42.4% year-over-year.
- Peak operating cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$23.1M | -42.4% |
| FY2022 | -$16.2M | -3.9% |
| FY2021 | -$15.6M | +22.9% |
| FY2020 | -$20.3M | -187.7% |
| FY2019 | -$7.0M | +57.7% |
| FY2018 | -$16.6M | -74.7% |
| FY2015 | -$9.5M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026